Observation on the Efficacy of Improving Ankle Dorsiflexion Limitation in Patients With Plantar Fasciitis

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Aug 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to treat plantar fasciitis, a common foot condition that causes heel pain. The trial is comparing traditional rehabilitation methods, which mainly focus on relaxing the plantar fascia and calf muscles, with a new approach that improves ankle movement. The goal is to see if helping patients move their ankles better can lead to less pain and improved daily activities, like walking and climbing stairs. The trial will last for eight weeks, and participants will do rehabilitation exercises at home five times a week.

To take part in this study, participants need to be between 30 and 60 years old, have been experiencing pain from plantar fasciitis for more than three months, and have specific limitations in ankle movement. Those who have had certain treatments or have other serious foot or health issues may not be eligible. This trial aims to help people with plantar fasciitis feel better and improve their quality of life by focusing on improving ankle function.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age range: 30-60 years old; disease course \> 3 months; pain cannot be relieved by conservative treatment such as rest, oral nonsteroidal drugs, and physical therapy; VAS score is less than 6 points.
• • 2. According to the clinical practice guidelines of the International Classification of Functioning, Disability and Health: Heel Pain/Plantar Fasciitis: 2014 Revision \[16\], patients meet the clinical diagnostic criteria for PF, mainly including pain on the medial side of the plantar, heel pain caused by recent weight-bearing activities, pain on palpation of the proximal attachment of the plantar fascia, and positive Windlass test;
• • 3. Supine straight knee ankle dorsiflexion angle \<10°; lunge knee flexion \<40° \[50, 51\]; left and right foot dorsiflexion difference does not exceed 1°.
• • 4. BMI between 18.5-23.9 (Chinese standard)
• Exclusion Criteria:
• • - (1) Those who have received local injections of steroids in the past 3 months; (2) Those with other foot, ankle and lower leg diseases: history of surgery, fracture, trauma, plantar skin ulcers, rheumatism or rheumatoid arthritis, etc.; (3) Those with serious medical diseases: such as blood diseases, coagulopathy, severe cardiovascular and cerebrovascular dysfunction, tumor diseases, etc.
• • (4) Those with peripheral neuropathy (idiopathic, diabetic, nutritional); L5/S1 neural foramen impingement or lumbar spinal stenosis (5) Congenital structural flat feet, equinus deformity or other foot and ankle joint diseases